Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptake.

[1]  Y. Bae,et al.  Bile Acid Conjugation on Solid Nanoparticles Enhances ASBT‐Mediated Endocytosis and Chylomicron Pathway but Weakens the Transcytosis by Inducing Transport Flow in a Cellular Negative Feedback Loop , 2022, Advanced science.

[2]  Yifa Zhou,et al.  Dual crosslinking of folic acid-modified pectin nanoparticles for enhanced oral insulin delivery. , 2022, Biomaterials advances.

[3]  R. Bogner,et al.  Impact of Formulation on the Quality and Stability of Freeze-dried Nanoparticles. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  Y. Choi,et al.  Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Sanyog Jain,et al.  Exploring protein stabilized multiple emulsion with permeation enhancer for oral delivery of insulin. , 2020, International journal of biological macromolecules.

[6]  Y. Bae,et al.  Bile acid transporter-mediated oral drug delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Q. Wang,et al.  Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges. , 2020, Pharmacology & therapeutics.

[8]  Z. Hosseinidoust,et al.  Liposomal Nanovesicles for Efficient Encapsulation of Staphylococcal Antibiotics , 2019, ACS omega.

[9]  O. Abdallah,et al.  Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate. , 2019, International journal of pharmaceutics.

[10]  Sanyog Jain,et al.  Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration , 2019, AAPS PharmSciTech.

[11]  Y. Bae,et al.  Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport. , 2018, ACS nano.

[12]  W. Pan,et al.  Self‐assembled liposome from multi‐layered fibrous mucoadhesive membrane for buccal delivery of drugs having high first‐pass metabolism , 2018, International journal of pharmaceutics.

[13]  Kwangmeyung Kim,et al.  Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex. , 2017, Biomaterials.

[14]  G. Ward,et al.  Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections , 2017, Transplantation.

[15]  Wessam H. Abd-elsalam,et al.  Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment. , 2016, International journal of pharmaceutics.

[16]  Laura M Ensign,et al.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[17]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[18]  D. Maahs,et al.  Insulin delivery methods: Past, present and future , 2016, International journal of pharmaceutical investigation.

[19]  B. Furman,et al.  Streptozotocin‐Induced Diabetic Models in Mice and Rats , 2015, Current protocols in pharmacology.

[20]  S. Xiao,et al.  EDC/NHS activation mechanism of polymethacrylic acid: anhydride versus NHS-ester , 2015 .

[21]  E. Moghimipour,et al.  Absorption-Enhancing Effects of Bile Salts , 2015, Molecules.

[22]  Y. S. Elnaggar.  Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine , 2015, International journal of nanomedicine.

[23]  W. Lin,et al.  Application of polymeric nanoparticles and micelles in insulin oral delivery , 2015, Journal of food and drug analysis.

[24]  M. H. Aburahma.  Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines , 2014, Drug delivery.

[25]  C. Chakraborti,et al.  Effect of different polymers on in vitro and ex vivo permeability of Ofloxacin from its mucoadhesive suspensions , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[26]  K. Thanki,et al.  Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. , 2014, Biomacromolecules.

[27]  F. Hu,et al.  Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. , 2013, International journal of pharmaceutics.

[28]  J. Johansson,et al.  Insulin solubility transitions by pH‐dependent interactions with proinsulin C‐peptide , 2012, The FEBS journal.

[29]  M. Saunders,et al.  Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. , 2012, Toxicology and applied pharmacology.

[30]  Mei-Chin Chen,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.

[31]  S. Xiao,et al.  Different EDC/NHS activation mechanisms between PAA and PMAA brushes and the following amidation reactions. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[32]  S. Bucak,et al.  Effect of preparation method and cholesterol on drug encapsulation studies by phospholipid liposomes. , 2011, Pharmaceutical development and technology.

[33]  N. Praphairaksit,et al.  Sustained Release of Amoxicillin from Ethyl Cellulose-Coated Amoxicillin/Chitosan–Cyclodextrin-Based Tablets , 2011, AAPS PharmSciTech.

[34]  G. Awad,et al.  Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. , 2010, International journal of pharmaceutics.

[35]  P. Opanasopit,et al.  In vitro Permeability Enhancement in Intestinal Epithelial Cells (Caco-2) Monolayer of Water Soluble Quaternary Ammonium Chitosan Derivatives , 2010, AAPS PharmSciTech.

[36]  H. Iyer,et al.  Oral insulin – a review of current status , 2010, Diabetes, obesity & metabolism.

[37]  Mushir M. Ali,et al.  Chemical permeation enhancers for transbuccal drug delivery , 2010, Expert opinion on drug delivery.

[38]  Yong-kyu Lee,et al.  Evaluation of the oral absorption of heparin conjugated with sodium deoxycholate as a facilitating agent in GI tract , 2009 .

[39]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[40]  M. Gallarate,et al.  Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: Development and influence on insulin stability , 2007, Journal of microencapsulation.

[41]  Hatem Fessi,et al.  Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[42]  J. Polli,et al.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. , 2006, Molecular pharmaceutics.

[43]  J. Polli,et al.  Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. , 2006, Molecular pharmaceutics.

[44]  M. Gallop,et al.  Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters. , 2005, Bioorganic & medicinal chemistry letters.

[45]  M. Korytkowski,et al.  When oral agents fail: practical barriers to starting insulin , 2002, International Journal of Obesity.

[46]  J. Brewer,et al.  Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). , 2001, Vaccine.

[47]  K. Hillgren,et al.  Enhanced transepithelial transport of peptides by conjugation to cholic acid. , 1997, Bioconjugate chemistry.

[48]  C. Craik,et al.  Use of the Intestinal Bile Acid Transporter for the Uptake of Cholic Acid Conjugates with HIV-1 Protease Inhibitory Activity , 1997, Pharmaceutical Research.

[49]  A. Oliva,et al.  Influence of temperature and shaking on stability of insulin preparations : degradation kinetics , 1996 .

[50]  K. Inui,et al.  Differences in effects on drug absorption between dihydroxy and trihydroxy bile salts. , 1985, Journal of pharmacobio-dynamics.

[51]  K. J. Mysels,et al.  The influence of bile salt structure on self-association in aqueous solutions. , 1983, The Journal of biological chemistry.

[52]  G. Benedek,et al.  Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. , 1980, Biochemistry.

[53]  F. Szoka,et al.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[54]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.

[55]  W. Herman.  The global burden of diabetes: An overview , 2017 .

[56]  Wei He,et al.  Biotinylated liposomes as potential carriers for the oral delivery of insulin. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[57]  G. Piérard,et al.  Lipodystrophy Reactions to Insulin , 2007, American journal of clinical dermatology.

[58]  R. Suryanarayanan,et al.  Crystallization Behavior of Mannitol in Frozen Aqueous Solutions , 2004, Pharmaceutical Research.

[59]  W. Rubas,et al.  A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. , 1997, Critical reviews in therapeutic drug carrier systems.

[60]  F. Szoka,et al.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. , 1980, Biochimica et biophysica acta.

[61]  D. Small,et al.  Detergent properties of bile salts: correlation with physiological function. , 1967, Annual review of medicine.